Next Generation Sequencing Panel for Analysis of Somatic (Solid Tumour and Haemato-oncology) Samples

Concepts

• cardiff
• laboratory reagents
• nhs wales shared services partnership-procurement services
• velindre university nhs trust
• vale university health board
• somatic ngs testing platform
• next generation
• analysis of somatic
• panel
• targeted panel

Location

All Wales Medical Genomics Laboratory, Cardiff and Vale University Health Board, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW

Description

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) on behalf of Cardiff and Vale University Health Board are looking to procurement a somatic NGS testing platform with a single workflow for both DNA and RNA library preparation. It must be a targeted panel of at least 500 genes for the DNA component and 50 genes for the RNA component which are of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).

Total Quantity or Scope

The All Wales Medical Genomics Laboratory (AWMGL) recently received an uplift in funding to enable the delivery of equitable testing for patients in Wales to patients in England who are eligible for tests detailed in the Genomics England National Genomics Test Directory for Cancer, thus, supporting AWMGL to work with Welsh clinicians to align services to the test directory. To enable successful alignment it is essential that the laboratory expands their services that are offered to those that are indicated as essential services in the Genomics England National Genomics Test Directory for Cancer 2020/2021 (https://www.england.nhs.uk/publication/national-genomic-test-directories/). To meet the service needs, AWMGL are looking to purchase a new DNA and RNA based single targeted somatic testing panel of at least 500 genes of clinical relevance to comprehensive cancer genomic profiling (including both current and future clinically actionable genes and those associated with clinical trials).

Award Detail

Award Criteria

CPV Codes

• 33696500 - Laboratory reagents

Indicators

• Award on basis of price and quality.

Other Information

1) The contracting authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract; 2) Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the contracting authority will not negotiate the terms; 3) The contracting authority will not accept completed ITT's after the stated closing date; 4) All documents to be priced (where applicable) in sterling and all payments made in sterling; 5) All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders; 6) Prospective suppliers should note that NHS Shared Services Partnership — Procurement Services is acting on behalf of Cardiff and Vale ULHB; 7) Bidders wishing to participate should visit the Bravo e-tenderwales portal and access the itt_83892 for all tender documentation. (WA Ref:110589)